Companies Dominating the HIV Drugs Landscape
- Merck & Co., Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Boehringer Ingelheim International GmbH
- Gilead Sciences, Inc.
- GlaxoSmithKline plc.
- F. Hoffmann-La Roche Ltd.
- Cipla Inc.
- Teva Pharmaceuticals Industries Ltd.
- Janssen Global Services, LLC
- Mylan N.V.
- AbbVie Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of HIV drugs is estimated at USD 38.62 billion.
HIV Drugs Market size was valued at USD 36.72 billion in 2024 and is likely to cross USD 79.29 billion by 2037, expanding at more than 6.1% CAGR during the forecast period i.e., between 2025-2037.
North America industry is anticipated to account for largest revenue share by 2037, on the back of presence of an ultra-modern healthcare system.
The major players in the market are F. Hoffmann-La Roche Ltd, Cipla Inc., Teva Pharmaceuticals Industries Ltd. and Janssen Global Services, LLC.
